lysophosphatidylserine 22:6

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 22 carbons and 6 double bonds.


A 1-acyl-sn-glycero-3-phosphoglycerol in which the acyl group is specified as palmitoyl (hexadecanoyl).


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as icosanoyl.


diphosphatidyl propylene glycol

A derivative of cardiolipin lacking the 2-hydroxy group of the central glycerol moiety.


A dialkylglycerophosphoethanolamine in which the amine group is substituted by a glycosyl group.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl group at position 1 is unspecified while that at position 2 is specified as lauroyl (dodecanoyl).


A 3-(3-sn-phosphatidyl)-sn-glycerol 1-phosphate in which the phosphatidyl acyl groups at positions 1 and 2 are specified as oleoyl and hexadecanoyl respectively.


A 1-phosphatidyl-D-myo-inositol in which the acyl group at position 1 is specified as stearoyl (octadecanoyl) while that at position 2 is unspecified.


triacylglycerol 47:0

A triglyceride in which the three acyl groups contain a total of 47 carbons and 0 double bonds.


An N-acyl-sn-glycero-3-phosphoethanolamine in which the N-acyl group is specified as octadecanoyl (stearoyl).


phosphatidylserine 34:2

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 34 carbon atoms and 2 double bonds.


lysophosphatidylserine 20:4

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 20 carbons and 4 double bonds.


A phosphatidylethanol in which both phosphatidyl acyl groups are specified as palmitoyl (hexadecanoyl).


A glycerophosphoinositol antigen having a 1-stearoyl-sn-glycero-3-phospho moiety attached at the 6-position of 1D-myo-inositol.


N-hexadecanoylphosphatidylethanolamine

An N-acylphosphatidylethanolamine in which the N-acyl group is specified as palmitoyl (hexadecanoyl).


lysophosphatidylinositol 18:1

A lysophosphatidyl-1D-myo-inositol in which the remaining acyl group (position not specified) contains 18 carbons and 1 double bond.


A triacylglycerol 53:6 in which the acyl groups at positions 1, 2 and 3 are specified as pentadecanoyl, octadecenoyl, and icosapentaenoyl respectively.


triacylglycerol 49:0

A triglyceride in which the three acyl groups contain a total of 49 carbons and 0 double bonds.


phosphatidylethanolamine 37:3

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at C-1 and C-2 contain 37 carbons in total with 3 double bonds.


A 1-acyl-sn-glycerophosphoserine in which the acyl group is specified as heptadecanoyl.


phosphatidic acid 18:0

A phosphatidic acid in which the two acyl groups contain a total of 18 carbons and no double bonds.


triacylglycerol 56:6

A triglyceride in which the three acyl groups contain a total of 56 carbons and 6 double bonds.


phosphatidic acid 18:3

A phosphatidic acid in which the two acyl groups contain a total of 18 carbons and 3 double bonds.


A 1-alkyl-3-acyl-sn-glycerol that has octadec-9-en-1-yl as the alkyl group and octadec-9-enoyl as the acyl group.


A GPI amidated group where R1 can be an alkyl or an acyl group, R2 is an acyl group, R3 can be an acyl group or an H, R4-8 can be other sugar groups, phosphoethanolamine or H.


phosphatidylglycerol 15:0/18:1

A phosphatidylglycerol 33:1 in which the acyl group at position 1 contains 15 carbons and no double bonds while that at position 2 contains 18 carbons and 1 double bond.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the phosphatidyl acyl groups at positions 1 and 2 are specified as oleoyl and lauroyl respectively.


1-acylglycerol 18:0

A 1-monoglyceride in which the acyl group contains 18 carbons and is fully saturated.


A fatty acid ester resulting from the formal condensation of the hydroxy group at position-1 of glycerol with the carboxy group of docosanoic acid.


lysophosphatidylserine 18:0

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 18 carbons and 0 double bonds.


A fatty acid ester resulting from the formal condensation of the hydroxy group at position-1 of glycerol with the carboxy group of tetracosanoic acid.


phosphatidylserine 35:2

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 35 carbon atoms and 2 double bonds.


lysophosphatidylethanolamine 20:0

A lysophosphatidylethanolamine in which the acyl group (position not specified) contains 20 carbons and is fully saturated.


phosphatidylserine 42:4

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 42 carbon atoms and 4 double bonds.


A 2,2'-lysobisphosphatidic acid in which both acyl groups are specified as oleoyl.


A 1-monoglyceride with tetradecanoyl (myristoyl) as the acyl group.


A triacylglycerol 53:2 in which the acyl group at position 1 is specified as heptadecanoyl while those at positions 2 and 3 are both octadecenoyl groups.


acyl-GPI

A glycosylphosphatidylinositol that can be attached to the C-terminal amino acid of a mature protein during posttranslational modification.  The phosphatidylinositol group is linked through a carbohydrate-containing linker (glucosamine and mannose glycosidically bound to the inositol residue) and via an ethanolamine phosphate bridge to the C-terminal amino acid, while the two fatty acids within the hydrophobic phosphatidylinositol group anchor the protein to the cell membrane.


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as linoleoyl.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as stearoyl and oleoyl respectively.


glycerophosphodimethylpropanethiol

The glycerol phosphate ester of a phosphodimethylpropanethiol.


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as lauroyl (dodecanoyl) while the phosphatidyl acyl groups are both specified as oleoyl (9Z-octadecenoyl).


A 1,1'-lysobisphosphatidic acid in which both acyl groups are specified as oleoyl.


triacylglycerol 53:6

A triglyceride in which the three acyl groups contain a total of 53 carbons and 6 double bonds.


A 1-acyl-sn-glycero-3-phosphoethanolamine in which the 1-acyl group is specified as hexadecanoyl (palmitoyl).


A triacylglycerol 50:2 in which the acyl groups at positions 1, 2 and 3 are specified as linoleoyl, oleoyl and isoheptadecanoyl respectively. It is a metabolite of the nematode Caenorhabditis elegans.


A 1-alkyl-2-acetyl-3-acyl-sn-glycerol in which the alkyl and acyl groups are specified as palmityl and lauroyl.


A triglyceride formed by acylation of the three hydroxy groups of glycerol with (10Z)-heptadecenoic acid.


An alkyl,acyl-sn-glycero-3-phospho-1D-myo-inositol in which positions 1 and 2 are substituted by unspecified alk-1-enyl and acyl groups respectively.


lysophosphatidylethanolamine (0:0/18:2)

A lysophosphatidylethanolamine 18:2 in which the acyl group is located at position 2.


phosphatidylglycerol 18:0/18:1

A phosphatidylglycerol 36:1 in which the acyl group at position 1 contains 18 carbons and no double bonds while that at position 2 contains 18 carbons and 1 double bond.


A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as stearoyl.


1,1'-lysobisphosphatidic acid

A lysobisphosphatidic acid carrying the fatty acyl groups at positions sn-2 and sn-2' of glycerol.


phosphatidic acid 37:0

A phosphatidic acid in which the two acyl groups contain a total of 37 carbons and no double bonds.


A CDP-diacylglycerol in which the acyl groups at positions 1 and 2 are specified as hexadec-9-enoyl.


lipoarabinomannan

A glycolipid comprising a glycosylphosphatidyl-myo-inositol-anchored lipoglycan; a virulence factor associated with Mycobacterium tuberculosis.


phosphatidylserine 34:1

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 34 carbon atoms and 1 double bond.


A glycerophosphoglycerol carrying alkyl and acyl substituents at positions 1 and 2 respectively.


lysophosphatidylethanolamine O-34:4

A 1-alkyl-sn-glycero-3-phosphoethanolamine in which the alkyl group contains 34 carbons and 4 double bonds.


A 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as (8Z,11Z,14Z,17Z)-icosatetraenoyl and (11Z)-icosenoyl respectively.


2-acylglycerol 22:5

A 2-monoglyceride in which the acyl group contains 22 carbons and 5 double bonds.


A 1-hexadecanoyl-2-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 2-acyl group is specified as 9Z-octadecenoyl (oleoyl).


A triacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl while that at position 3 is specifed as lauroyl.


A 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as (13Z,16Z)-docosadienoyl and hexadecanoyl respectively.


triacylglycerol 47:1

A triglyceride in which the three acyl groups contain a total of 47 carbons and 1 double bond.


An N-glycosylated dialkylglycerophosphoethanolamine in which the alkyl groups are hexadecyl, the glycerol core has sn stereochemistry and the phosphoethanolamine unit is at position 3 and substituted on nitrogen with the branched heptasaccharide beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc.


A lysobisphosphatidic acid with (R,R)-configuration in which both acyl groups are specified as oleoyl and are located at the 2 and 2'-positions.


triacylglycerol 62:14

A triglyceride in which the three acyl groups contain a total of 62 carbons and 14 double bonds.


A member of the class of glycerophosphoglycerols obtained by formal condensation of the carboxy group of oleic acid with one of the secondary hydroxy groups of (S,S)-glycero-1-phospho-1'-glycerol


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups specified at position 1 and 2 are octadecenoyl and icosatetraenoyl respectively.


A 1-[(Z)-alk-1-enyl]-sn-glycero-3-phospho-(N-acyl)ethanolamine in which the alk-1-enyl and N-acyl groups are specified as 1Z-octadecenyl and oleoyl respectively.


trimyristin

A triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by myristic (tetradecanoic) acid.


lysophosphatidylethanolamine O-18:1

A monoalkyl-sn-glycero-3-phosphoethanolamine in which the alkyl group (position unspecified) contains 18 carbons and 1 double bond.


A phosphatidyl-N,N-dimethylethanolamine (1,2-diacylglycero-3-phospho-N,N-dimethylethanolamine) in which the stereochemistry of the glycerol moiety is specified as sn.


phosphatidylinositol

Any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.


lysophosphatidylinositol 17:1

A lysophosphatidyl-1D-myo-inositol in which the remaining acyl group (position not specified) contains 17 carbons and 1 double bond.


An inositol compound having an alpha-2-(2-aminoethylphosphoryl)mannosyl-alpha-glucosaminyl group at the 6-position, a phosphatidyl group at the 1-position and an undefined acyl substituent at an unspecified position.


monoacylglycerol 14:0

A monoglyceride in which the acyl contains a total of 14 carbon atoms and 0 double bonds.


The members of the class of phosphatidylethanolamines which have the L-glycero-1-phosphate (D-glycero-3-phosphate) configuration.


monoacylglycerol 18:0

A monoglyceride in which the acyl group contains a total of 18 carbon atoms and 0 double bonds.


A cardiolipin in which the phosphatidyl acyl groups at positions 1, 1' and 2 are specified as linoleoyl, while that at position 2' is specified as oleoyl.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as (9Z)-octadec-9-enoyl (oleoyl) and hexadecanoyl (palmitoyl) respectively.


triacylglycerol 54:6

A triglyceride in which the three acyl groups contain a total of 54 carbons and 6 double bonds.


A 1-monoglyceride that has octanoyl as the acyl group.


Any glycerophospholipid consisting of any 1-O-[(Z)-alk-1-enyl]-sn-glycero-3-phosphoethanolamine in which one of the amino hydrogens has been replaced by an acyl group.


triacylglycerol 58:6

A triglyceride in which the three acyl groups contain a total of 58 carbons and 6 double bonds.


A 3-acyl-sn-glycerol in which the acyl group is specified as palmitoyl (hexadecanoyl).


A 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate in which both phosphatidyl acyl groups are specified as palmitoyl (hexadecanoyl).


triacylglycerol 62:8

A triglyceride in which the three acyl groups contain a total of 62 carbons and 8 double bonds.


phosphatidylethanolamine 38:5

A phosphatidylethanolamine in which the two acyl groups contain a total of 38 carbons and 5 double bonds.


triacylglycerol 55:4

A triglyceride in which the three acyl groups contain a total of 55 carbons and 4 double bonds.


A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as heptadecanoyl.


A phosphatidylinositol dimannoside having the phosphatidyl moiety (with acyl groups palmitoyl and tuberculostearoyl at the 1- and 2-positions respectively) at the 1-position, and with two single mannosyl residues at the 2- and 6-positions of the inositol ring.


A triglyceride in which the acyl groups at positions 1 and 2 are specified as palmitoyl while that at position 3 is specified as palmitoleoyl.


triacylglycerol 46:6

A triglyceride in which the three acyl groups contain a total of 46 carbons and 6 double bonds.


A phosphatidic acid (36:2) in which both acyl groups are specified as octadec-9-enoyl.


lysophosphatidylserine 26:0

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 26 carbons and 0 double bonds.


An alkyl,acyl-sn-glycero-3-phospho-1D-myo-inositol in which unspecified alkyl and acyl groups are located at positions 1 and 2 respectively.


triacylglycerol 58:9

A triglyceride in which the three acyl groups contain a total of 58 carbons and 9 double bonds.


phosphatidylinositol 36:1

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 36 carbon atoms and 1 double bond.


phosphatidylsulfocholine

A glycerophospholipid consisting of glycerosulfocholine having O-acyl substituents at both the 1- and 2-positions of the glycerol.


A 3-acyl-sn-glycerol that is the R-enantiomer of 1-myristoyl glycerol.


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (11Z,14Z)-icosadienoyl.


An inositol compound having an alpha-mannosyl-(1->6)-alpha-2-(2-aminoethylphosphoryl)mannosyl-alpha-glucosaminyl group at the 6-position, a phosphatidyl group at the 1-position and an undefined acyl substituent at an unspecified position.


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as capryloyl (octanoyl) while the phosphatidyl acyl groups at position 1 and 2 are specified as palmitoyl (hexadecanoyl) and linoleoyl (9Z,12Z-octadecadienoyl) respectively.


A lysophosphatidylethanolamine obtained by selective hydrolysis of the 1-acyl substituent of any 1,2-diacyl-sn-glycero-3-phosphoethanolamine.


phosphatidylinositol 37:5

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 37 carbon atoms and 5 double bonds.


lysophosphatidylinositol 15:0

A lysophosphatidyl-1D-myo-inositol in which the remaining acyl group (position not specified) contains 15 carbons and 0 double bonds.


1,2-dimyristoyl phosphatidyl-L-serine

A phosphatidyl-L-serine in which the phosphatidyl acyl groups are both myristoyl.


A glycerophospholipid that is a lysophospholipid where only R1 or R2 is an acyl chain, the other is a hydrogen, and R3 is any group that represents the different classes of glycerophospholipids (choline, ethanolamine, inositol, etc).


A glycerophosphoethanolamine obtained by formal condensation of the carboxy group of hexadecanoic acid with the amino group of 1-[(1Z)-octadecenoyl]-2-oleoyl-sn-glycero-3-phosphoethanolamine.


CDP-dipalmitoyl-sn-glycerol

A CDP-diacylglycerol in which both of the phosphatidyl acyl groups are specified as palmitoyl (hexadecanoyl).


A 3-sn-phosphatidyl-L-serine compound with a palmitoyl group at the 1-position and an oleoyl group at the 2-position.


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as oleoyl.


phosphatidylinositol 34:2

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 34 carbon atoms and 2 double bonds.


A 3-sn-phosphatidyl L-serine in which the phosphatidyl acyl groups at both positions 1 and 2 are specified as hexadecanoyl (palmitoyl).


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as octadecanoyl (stearoyl) and 9Z-octadecenoyl (oleoyl) respectively.


triacylglycerol 52:2

A triglyceride in which the three acyl groups contain a total of 52 carbons and 2 double bonds.


A triglyceride where at least one of the primary OH groups in the glycerol backbone has a linoleoyl chain.


A glycerophosphoinositol phosphate having a 1-O,2-O-dioctanoyl-sn-glycero-3-phospho moiety attached at the 1-position of 1D-myo-inositol 4,5-bis(phosphate).


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as caproyl (hexanoyl) while the phosphatidyl acyl groups at position 1 and 2 are specified as palmitoyl (hexadecanoyl) and linoleoyl (9Z,12Z-octadecadienoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as (9Z)-hexadec-9-enoyl (pamitoleoyl) and octadecanoyl (stearoyl) respectively.


A glycerophosphoglycerol that is sn-glycero-3-phosphoglycerol in which positions 1 and 2 are substituted by unspecified acyl and alkyl groups, and in which the positions of the acyl and alkyl groups are also unspecified.


A 3-acyl-sn-glycerol that has octanoyl as the 3-acyl group.


phosphatidylglycerol O-36:1

An alkyl,acyl-sn-glycero-3-phosphoglycerol in which the alkyl or acyl groups at positions 1 and 2 contain a total of 36 carbons and 1 double bond.


N-acyllysophosphatidylethanolamine

Any glycerophospholipid consisting of a lysophosphatidylethanolamine in which one of the amino hydrogens is replaced by an acyl group.


OMPT

A glycerophospholipid obtained by formal condensation of the carboxy group of oleic acid with the primary hydroxy group of (2S)-2-methylglycero-3-phosphothionate.


A 1-acyl-2-hexadecanoyl-sn-glycero-3-phosphate in which the 1-acyl group is specified as oleoyl (9Z-octadecaenoyl).


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as tetradecanoyl (myristoyl) and hexadecanoyl (palmitoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at positions 1 and 2 are both specified as (9Z,11Z)-octadecadienoyl.


An alkyl,acyl-sn-glycero-3-phosphoserine in which unspecified alkyl and acyl groups are located at positions 1 and 2 respectively.


triacylglycerol 60:12

A triglyceride in which the three acyl groups contain a total of 60 carbons and 12 double bonds.


A phosphatidic acid in which one acyl group has 18 carbons and is fully saturated while the other has 22 carbons and 4 double bonds.


A triglyceride in which the acyl groups at positions 1 and 3 are specified as oleoyl while that at position 2 is specified as palmitoyl.


phosphatidylethanolamine 39:6

A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the two acyl groups contain a total of 39 carbons and 6 double bonds.


A 1-phosphatidyl-D-myo-inositol in which the acyl group at position 1 is unspecified while that at position 2 is specified as palmitoyl (hexadecanoyl).


lysophosphatidylethanolamine 22:4

A lysophosphatidylethanolamine in which the acyl group (position not specified) contains 22 carbons and 4 double bonds.


triacylglycerol 47:2

A triglyceride in which the three acyl groups contain a total of 47 carbons and 4 double bonds.


phosphatidylserine 42:9

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 42 carbons and 9 double bonds.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituent both at positions 1 and 2 is specified as (6Z)-octadecenoyl respectively.


triacylglycerol 60:3

A triglyceride in which the three acyl groups contain a total of 60 carbons and 3 double bonds.


A phosphatidylglycerol (18:3/16:1) in which the 1- and 2-acyl groups are specified as alpha-linolenoyl and (3E)-hexadecenoyl respectively.


A 1-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 1-acyl group is specified as linoleoyl.


name: phosphatidylethanolamine amidated glycine zwitterion


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (5Z,8Z,11Z,14Z)-eicosatetraenoyl (arachidonoyl).


phosphatidylserine 40:1

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 40 carbon atoms and 1 double bond.


phosphatidylglycerol phosphate

A phosphatidylglycerol in which one of the hydroxy groups of the glycerol moiety has been converted to the corresponding dihydrogen phosphate.


phosphatidylserine 38:3

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 38 carbon atoms and 3 double bonds.


A 1-alkyl-2-acyl-sn-glycero-3-phosphserine in which the alkyl and acyl groups are specified as (1Z)-octadecenyl and oleoyl respectively.


name: Glycerol 1-(9Z-octadecenoate) 2-hexadecanoate 3-octadecanoate


A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as icosanoyl (arachidoyl).


triacylglycerol 53:7

A triglyceride in which the three acyl groups contain a total of 53 carbons and 7 double bonds.


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as palmitoyl while the phosphatidyl acyl groups are both specified as oleoyl.


1-palmitoylglycerol 3-phosphate

A monoacylglycerol phosphate having palmitoyl as the acyl group on O-1 and with the phosphate group on O-3.


triacylglycerol 51:2

A triglyceride in which the three acyl groups contain a total of 51 carbons and 2 double bonds.


A 3-sn-phosphatidyl-L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are specified as oleoyl and linoleoyl respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which both acyl groups are specified as oleoyl.


phosphatidylinositol 34:0

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 34 carbon atoms and no double bonds.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as oleoyl and palmitoyl respectively.


N-arachidonoylphosphatidylethanolamine

An acyl derivative of phosphatidic acid whose phosphorus acid component is esterified with 2-N-arachidonoylaminoethanol.


A 1-acylglycerophosphoinositol in which sn-glycerol, acylated at O(1), is linked through a phospho group at O(3) to O(1) of D-myo-inositol.


A 1-phosphatidyl-1D-myo-inositol 4-phosphate in which the phosphatidyl acyl groups at positions 1 and 2 are specified as stearoyl and oleoyl respectively.


phosphatidylserine 40:6

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 40 carbon atoms and 6 double bonds.


triacylglycerol 51:4

A triglyceride in which the three acyl groups contain a total of 51 carbons and 4 double bonds.


A triacylglycerol 54:8 in which the acyl groups at positions 1, 2 and 3 are specified as tetradecanoyl, octadecadienoyl and docosahexaenoyl respectively.


triacylglycerol 56:2

A triglyceride in which the three acyl groups contain a total of 56 carbons and 2 double bonds.


lysophosphatidylglycerol 12:0

A lysophosphatidylglycerol in which the acyl group has a fully saturated C12 chain and is attached to the glycero moiety at either position 1 or 2.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are both specified as hexadecanoyl (palmitoyl).


lysophosphatidic acid 18:0

A lysophosphatidic acid in which the acyl group (position not specified) contains 18 carbons and no double bonds.


phosphatidylglycerol P-34:3

1-(alk-1-enyl)-2-acyl-sn-glycero-3-phosphoglycerol in which the alk-1-enyl and acyl groups at positions 1 and 2 contain 34 carbon atoms in total with 3 additional double bonds.


1-phosphatidyl-1D-myo-inositol in which the 2-acyl group is specified as (5Z,8Z,11Z,14Z)-eicosatetraenoyl (arachidonoyl).


An optically active form of 1,2-distearoylphosphatidylethanolamine having (S)-configuration.


A phosphatidylglycerol (18:3/16:0) in which the 1- and 2-acyl groups are specified as alpha-linolenoyl and hexadecanoyl respectoively.


triacylglycerol 54:1

A triglyceride in which the three acyl groups contain a total of 54 carbons and 1 double bond.


A triacyl-sn-glycerol in which the which the acyl groups at positions 1, 2 and 3 are specified as tetradecanoyl, hexadecanoyl and octadecanoyl respectively.


triacylglycerol 46:0

A triglyceride in which the three acyl groups contain a total of 46 carbons and 0 double bonds.


A galactoglycerolipid in which positions 1 and 2 are substituted by unspecified acyl and alkyl groups, the positions of which are also unspecified.


triacylglycerol 55:8

A triglyceride in which the three acyl groups contain a total of 55 carbons and 8 double bonds.


triacylglycerol 50:5

A triglyceride in which the three acyl groups contain a total of 50 carbons and 5 double bonds.


A 3-acyl-sn-glycerol in which the acyl group is (9Z)-octadec-9-enoyl.


A triacylglycerol 54:8 in which the acyl groups at positions 1 and 2 are specified as hexadecenoyl, while that at position 3 is docosahexaenoyl.


phosphatidylinositol 44:0

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 44 carbon atoms and no double bonds.


A triacylglycerol 56:3 in which the acyl groups at positions 1 and 2 are specified as octadecanoyl, while that at position 3 is docosapentaenoyl.


A 3-sn-phosphatidyl-L-serine in which the two phosphatidyl acyl groups are specified as octanoyl.


A 1-monoglyceride that has decanoyl (capryl) as the acyl group.


phosphoinositide

Any phosphatidylinositol that is phosphorylated at one or more of the hydroxy groups of inositol.


A 1-monoglyceride that has octadecadienoyl (linoleoyl) as the acyl group.


phosphatidylglycerol 14:0/18:1

A phosphatidylglycerol 32:1 in which the acyl group at position 1 contains 14 carbons and no double bonds while that at position 2 contains 18 carbons and 1 double bond.


A 3-sn-phosphatidyl-L-serine in which the acyl substituents at positions 1 and 2 are specified as heptadecanoyl and arachidonoyl respectively.


triacylglycerol 60:10

A triglyceride in which the three acyl groups contain a total of 60 carbons and 10 double bonds.


triacylglycerol 45:0

A triglyceride in which the three acyl groups contain a total of 45 carbons and 0 double bonds.


A triacylglycerol 53:3 in which the acyl groups at positions 1, 2 and 3 are specified as heptadecanoyl, octadecenoyl and octadecadienoyl respectively.


phosphatidylethanolamine 40:9

A phosphatidylethanolamine in which the two acyl groups contain a total of 40 carbons and 9 double bonds.


A triglyceride in which the acyl groups at positions 1 and 2 are specified as oleoyl while that at position 3 is specified as palmitoyl.


dimethyl cardiolipin

The dimethyl phosphate ester of cardiolipin.


phosphatidylinositol 38:4

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 38 carbon atoms and 4 double bonds.


A 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate in which the phosphatidyl acyl groups at positions 1 and 2 are both specified as octanoyl.


A triacylglycerol 58:11 in which the acyl groups at positions 1, 2 and 3 are specified as hexadecenoyl, icosatetraenoyl and docosahexaenoyl respectively.


phosphatidylserine 38:5

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 38 carbon atoms and 5 double bonds.


1,2-diacyl-sn-glycerol 3-phosphate

An sn-glycerol 3-phosphate compound having unspecified O-acyl groups at the 1- and 2-positions.


A phosphatidylinositol 3-phosphate in which both phosphatidyl acyl groups are specified as palmitoyl (hexadecanoyl)


A 3-acyl-sn-glycerol that is the R-enantiomer of 1-monolinolein.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which both the acyl groups specified is (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl.


triacylglycerol 54:8

A triglyceride in which the three acyl groups contain a total of 54 carbons and 8 double bonds.


phosphatidylethanolamine 19:1

A 1,2-diacyl-sn-glycero-3-phosphoethanolaminein which the two phosphatidyl acyl groups contain a total of 19 carbons and 1 double bond.


lysophosphatidylethanolamine

A glycerophosphoethanolamine resulting from partial hydrolysis of a phosphatidylethanolamine, which removes one of the fatty acid groups. The structure is depicted in the image where R(1) = acyl, R(2) = H or where R(1) = H, R(2) = acyl.


lysophosphatidylglycerol 14:0

A lysophosphatidylglycerol in which the acyl group has a fully saturated C14 chain and is attached to the glycero moiety at either position 1 or 2.


triacylglycerol 44:4

A triglyceride in which the three acyl groups contain a total of 44 carbons and 4 double bonds.


triacylglycerol 38:0

A triglyceride in which the three acyl groups contain a total of 38 carbons and no double bonds.


triacylglycerol 58:11

A triglyceride in which the three acyl groups contain a total of 58 carbons and 11 double bonds.


A triacylglycerol 58:11 in which the acyl groups at positions 1, 2 and 3 are specified as octadecadienoyl, octadecatrienoyl and docosahexaenoyl respectively.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and octadecanoyl (stearoyl) respectively.


A 1-phosphatidyl-1D-myo-inositol 5-phosphate in which both phosphatidyl acyl groups are specified as palmitoyl (hexadecanoyl).


A 1-alkyl-3-acylglycerol in which the alkyl and acyl groups are specified as palmityl (hexadecyl) and oleoyl.


A lysophosphatidylethanolamine 18:1 in which the acyl group is located at position 1.


A triacylglycerol 62:10 in which the acyl group at position 1 is specified as octadecanoyl while those at positions 2 and 3 are both docosapentaenoyl groups.


glycerophospholipid

Any glycerolipid having a phosphate group ester-linked to a terminal carbon of the glycerol backbone.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituents at positions 1 and 2 are specified as oleoyl and stearoyl respectively.


A 1-acyl-sn-glycerol that has octanoyl as the 1-acyl group.


A 1-acyl-sn-glycerol that is the S-enantiomer of 1-myristoyl glycerol.


A 1-acyl-sn-glycerol 3-phosphate in which the 1-acyl substituent is specified as linolenoyl (9Z,12Z,15Z-octadecatrienoyl).


lysophosphatidylethanolamine 18:0

A lysophosphatidylethanolamine in which the acyl group has a fully saturated C18 chain and is attached to the glycero moiety at either position 1 or 2.


lysophosphatidylinositol 16:1

A lysophosphatidyl-1D-myo-inositol in which the remaining acyl group (position not specified) contains 16 carbons and 1 double bond.


A 1-monoglyceride resulting from the formal condensation of 1-(all-cis-docosa-7,10,13,16-tetraenoic acid (adrenic acid) with one of the primary hydroxy groups of glycerol.


A triacylglycerol 62:12 in which the acyl group at position 1 is specified as octadecanoyl while those at positions 2 and 3 are both docosahexaenoyl groups.


lysophosphatidylglycerol 18:1/0:0

A lysophosphatidylglycerol 18:1 in which the acyl group is located at position 1.


lysophosphatidic acids

Any monoacylglycerol phosphate obtained by hydrolytic removal of one of the two acyl groups of any phosphatidic acid or derivatives therein.


A triacylglycerol 54:5 in which the acyl groups at positions 1, 2 and 3 are specified as hexadecanoyl, octadecadienoy and icosatrienoyl respectively.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the 1- and 2-acyl substituent are specified as oleoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively; major species at pH 7.3.


triacyl-sn-glycerol

Any optically active triglyceride that has R-configuration.


bacilysocin

A carboxylic ester resulting from the formal condensation of the carboxylic acid group of 12-methyltetradecanoic acide with one of the primary alcoholic hydroxy groups of glycerophosphoglycerol. An antibiotic obtained from Bacillus subtilis 168, it has particular activity against certain fungi. The stereochemistries of the hydroxy groups at positions C-2 and C-2' and the methyl group at position C-12 have not been determined.


A phosphatidylinositol mannoside consisting of alpha-D-mannopyranose and 6-acyl-alpha-D-mannopyranose residues attached at positions 2 and 6 respectively of 1-phosphatidyl-1D-myo-inositol via glycosidic linkages.


lysophosphatidylethanolamine 12:0

A lysophosphatidylethanolamine in which the acyl group has a fully saturated C12 chain and is attached to the glycero moiety at either position 1 or 2.


A 1,2-diacyl-sn-glycerol 3-phosphate in which both phosphatidyl acyl groups are specified as (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl.


mannosyl diphosphorylinositol ceramide

Any lipid with a phosphodiester bridge between an inositol residue and the ceramide group which contains two phosphoryl groups and a mannose residue.


A 1-hexadecanoyl-2-acyl-sn-glycero-3-phospho-1D-myo-inositol in which the 2-acyl group is specified as 9Z,12Z-octadecadienoyl (linoleoyl).


2-acylglycerol 16:1

A 2-monoglyceride in which the acyl group contains 16 carbons and 1 double bond.


triacylglycerol 48:0

A triglyceride in which the three acyl groups contain a total of 48 carbons and 0 double bonds.


An N-acylphosphatidylethanolamine in which the N-acyl group and the phosphatidyl acyl groups are specified as oleoyl (9Z-octadecenoyl).


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as hexadecanoyl while the phosphatidyl acyl groups at position 1 and 2 are specified as hexadecanoyl and (9Z,12Z-octadecadienoyl) respectively.


2-acylglycerol 18:2

A 2-monoglyceride in which the acyl group contains 18 carbons and 2 double bonds.


A glycerophospholipid obtained by formal condensation of the carboxy group of any carboxylic acid with the amino group of any 1-[(1Z)-alkenyl]-2-acyl-sn-glycero-3-phosphoethanolamine.


An alkyl,acyl-sn-glycero-3-phospho-1D-myo-inositol in which unspecified acyl and alkyl groups are located at positions 1 and 2 respectively.


dioleoyl phosphatidylglycerol

A phosphatidylglycerol in which the phosphatidyl acyl groups are both oleoyl.


phosphatidylinositol 5-phosphate

A phosphatidylinositol monophosphate carrying the phosphate group at the 5-position.


A 1-[(Z)-alk-1-enyl]-sn-glycero-3-phospho-(N-acyl)ethanolamine in which the alk-1-enyl and N-acyl groups are specified as 1Z-octadecenyl and hexadecanoyl respectively.


lysophosphatidylethanolamine 20:4

An acyl-sn-glycero-3-phosphoethanolamine in which the acyl group contains twenty carbons and four double bonds. If R1 is an acyl group and R2 is a hydrogen then the molecule is a 1-acyl-sn-glycero-3-phosphoethanolamine. If R1 is a hydrogen and R2 is an acyl group then the molecule is a 2-acyl-sn-glycero-3-phosphoethanolamine.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as oleoyl and (11Z)-octadecenoyl respectively.


triacylglycerol 62:13

A triglyceride in which the three acyl groups contain a total of 62 carbons and 13 double bonds.


A 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate in which the phosphatidyl acyl groups at positions 1 and 2 are both specified as octanoyl.


A dialkylglycerophosphoethanolamine in which the alkyl groups are hexadecyl and the glycerol core has sn stereochemistry with the phosphoethanolamine unit at position 3.


1-phosphatidyl-1D-myo-inositol in which the 1- and 2-acyl groups are specified as (5Z,8Z,11Z,14Z,17Z)-docosapent-5,8,11,14,17-enoyl and octadecanoyl (stearoyl) respectively.


A phosphatidylethanolamine 38:2 in which one acyl group has 18 carbons and 1 double bond while the other has 20 carbons and 1 double bond (position not specified).


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and (8Z,11Z,14Z)-icosatrienoyl respectively.


A monoglyceride that is 1-oleoyl-sn-glycerol in which the hydroxyl hydrogen at position 2 is replaced by an arachidonyl group.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 5Z,8Z,11Z,14Z-eicosatetraenoyl (arachidonoyl) respectively.


A monoglyceride in which the acyl substituent is located at position 2.


A fatty acid ester resulting from the formal condensation of the hydroxy group at position-1 of glycerol with the carboxy group of (15Z)-tetracosenoic acid.


phosphatidylethanolamine 38:2

A phosphatidylethanolamine in which the two acyl groups contain a total of 38 carbons and 2 double bonds.


A 1,2-diacyl-sn-glycero-3-phosphate in which the acyl groups at positions 1 and 2 are specified as capryl (decanoyl).


A 1-phosphatidyl-1D-myo-inositol 5-phosphate in which both phosphatidyl acyl groups are specified as linoleoyl.


cardiolipin

A phosphatidylglycerol composed of two molecules of phosphatidic acid covalently linked to a molecule of glycerol.


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as oleoyl; major species at pH 7.3.


dihexadecanoyl phosphatidic acid

A phosphatidic acid in which the phosphatidyl acyl groups are both palmitoyl (hexadecanoyl).


triacylglycerol 62:15

A triglyceride in which the three acyl groups contain a total of 62 carbons and 15 double bonds.


A 2-monolysocardiolipinin which the remaining phosphatidyl acyl groups at positions 1 and 1' are specified as linoleoyl while that at position 2' is  specified as oleoyl.


lysophosphatidylethanolamine P-34:3

A 1-(Z-alk-1-enyl)-sn-glycero-3-phosphoethanolamine in which the alkenyl group contains 34 carbons and has 3 additional double bonds.


triacylglycerol 48:1

A triglyceride in which the three acyl groups contain a total of 48 carbons and 1 double bond.


A phosphatidylglycerol (18:2/16:1) in which the 1- and 2-acyl groups are specified as linoleoyl and (3E)-hexadecenoyl respectively.


A triacyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as oleoyl while that at position 3 is specifed as myristoyl.


phosphatidylglycerol 16:0/16:1

A phosphatidylglycerol 32:1 in which the acyl group at position 1 contains 16 carbons and no double bonds while that at position 2 contains 16 carbons and 1 double bond.


A 2-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as (11R)-hydroxy-(5Z,8Z,12E,14Z)-icosatetraenoyl.


A CDP-diacylglycerol in which the acyl groups at positions 1 and 2 are specified as tetradecanoyl.


phosphatidylglycerol 34:4

A phosphatidylglycerol in which the two acyl groups contain 34 carbon atoms and 4 double bonds.


A 1-acyl-sn-glycerophosphoserine compound having an oleoyl substituent at the 1-hydroxy position.


A 1-alkyl-sn-glycero-3-phosphoethanolamine in which the alkyl group at C-1 is specified as hexadecyl.


A glucosaminylphosphatidylinositol compound consisting of D-glucosamine joined to 1-phosphatidyl-1D-myo-inositol via a (1->6)-alpha-linkage.


An N-glycosylated dialkylglycerophosphoethanolamine in which the dialkylglycerophosphoethanolamine is AOPE and the glycosylating saccharide is the branched nonasaccharide alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->3)-[alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-GlcNAc-(1->4)-D-GlcNAc.


A phosphatidylethanolamine 37:3 in which the acyl groups at positions 1 and 2 are specified as nonadecanoyl and (9Z,12Z,15Z)-octadecatrienoyl, respectively.


A 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as (8Z,11Z,14Z,17Z)-icosatetraenoyl and arachidoyl (icosanoyl) respectively.


tripropionin

A triglyceride obtained by formal acylation of the three hydroxy groups of glycerol by propionic acid.


A 1-monoglyceride in which the acyl group is specified as (9Z)-hexadecenoyl.


A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as arachidonoyl.


phosphatidylinositol pentamannoside

A glycosylphosphatidylinositol having a pentamannose moiety of unspecified composition as the glycosyl fragment; obtained via extraction of the cell wall of Mycobacterium bovis.


A lysoglycerophospholipid that has an acyl group at position sn-1.


name: phosphatidyl (3,4) inositol bisphosphate

description: A 1-phosphatidyl-1D-myo-inositol 3,4-bisphosphate in which the phosphatidyl acyl groups at positions 1 and 2 are both specified as hexadecanoyl (palmitoyl).


phosphatidylethanolamine 38:3

A phosphatidylethanolamine in which the acyl groups at C-1 and C-2 contain 38 carbons in total with 3 double bonds.


A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as linoleoyl.


A CDP-diacylglycerol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as palmitoyl and arachidonoyl respectively.


A 1-acyl-sn-glycerol that has hexadecanoyl (palmitoyl) as the 1-acyl group.


1-acylglycerol 16:1

A 1-monoglyceride in which the acyl group contains 16 carbons and 1 double bond.


name: Pyrrolidinium, 1-[(7r)-7-(acetyloxy)-4-hydroxy-4-oxido-3,5,9-trioxa-4-phosphapentacos-1-yl]-1-methyl-, inner salt


triacylglycerol 58:5

A triglyceride in which the three acyl groups contain a total of 58 carbons and 5 double bonds.


triacylglycerol 49:1

A triglyceride in which the three acyl groups contain a total of 49 carbons and 1 double bond.


A 1-acyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the 1-acyl substituent is specified as hexadecanoyl (palmitoyl).


2-acylglycerol 16:0

A 2-monoglyceride in which the acyl group contains 16 carbons and is fully saturated.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and 5Z,8Z,11Z,14Z-eicosatetraenoyl (arachidonoyl) respectively.


A 2-acyl-sn-glycero-3-phospho-D-myo-inositol that has palmitoleoyl as the acyl group.


1-acylglycerol 16:0

A 1-monoglyceride in which the acyl group contains 16 carbons and is fully saturated.


tricaproin

A triglyceride obtained by condensation of each of the three hydroxy groups of glycerol with hexanoic (caproic) acid.


A 1-alkyl-sn-glycero-3-phosphoethanolamine in which the alkyl substituent can be any Z-alk-1-enyl group.


triacylglycerol 56:5

A triglyceride in which the three acyl groups contain a total of 56 carbons and 5 double bonds.


lysophosphatidylethanolamine 16:0

A lysophosphatidylethanolamine in which the acyl group has a fully saturated C16 chain and is attached to the glycero moiety at either position 1 or 2.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as oleoyl and heptadecanoyl respectively.


A phosphatidylinositol 36:1 in which one acyl group has 18 carbons and is fully saturated while the other has 18 carbons and 1 double bond (position not specified).


phosphatidic acid 36:2

A phosphatidic acid in which the two acyl groups contain a total of 36 carbons and 2 double bonds.


A 2-acyl-sn-glycero-3-phosphoserine in which the acyl group is specified as oleoyl.


N-acylphosphatidylethanolamine

A phosphatidylethanolamine in which the amine function has formed an amide with a fatty acid RCO2H.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as heptadecanoyl and oleoyl respectively.


An inositol compound having alpha-mannosyl-(1->2)-alpha-mannosyl-(1->6)-alpha-2-(2-aminoethylphosphoryl)mannosyl-beta-glucosaminyl and phosphatidyl substituents on its hydroxy groups.


A glycerophosphoethanolamine having an unspecified O-acyl substituent at the 1-position of the glycerol fragment.


A 3-sn-phosphatidyl-L-serine in which the 1- and 2-acyl groups are octadecenoyl and docosenoyl respectively.


A triacylglycerol 52:1 in which the acyl groups at positions 1, 2 and 3 are specified as hexadecanoyl, octadecanoyl and octadecenoyl respectively.


An sn-glycerophosphoserine compound having an acyl substituent at the 1-hydroxy position.


A triglyceride formed by acylation of the three hydroxy groups of glycerol with linoleic acid.


lysophosphatidylglycerol 16:1

A lysophosphatidylglycerol in which the acyl group (position of attachment not specified) contains 16 carbons and 1 double bond.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as myristoyl and oleoyl respectively.


An alkyl,acyl-sn-glycero-3-phospho-1D-myo-inositol-5-phosphate in which unspecified alkyl and acyl groups are located at positions sn-1 and sn-2 respectively. Major microspecies at pH 7.3


phosphatidylserine 40:2

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 40 carbon atoms and 2 double bonds.


triacylglycerol 53:8

A triglyceride in which the three acyl groups contain a total of 53 carbons and 8 double bonds.


The deacylated homologue of mono(p-azobenzenearsonic acid)-L-tyrosylphosphatidylethanolamine.


phosphatidylinositol 39:4

A 1-phosphatidyl-1D-myo-inositol in which the two acyl groups contain a total of 39 carbon atoms and 4 double bonds.


phosphatidylethanolamine 42:5

A phosphatidylethanolamine in which the acyl groups at C-1 and C-2 contain 42 carbons in total with 5 double bonds.


1-acylglycerol 18:1

A 1-monoglyceride in which the acyl group contains 18 carbons and 1 double bond.


A 1-acyl-sn-glycero 3-phospho-(1'-sn-glycerol) in which the acyl group is specified as octadecanoyl (stearoyl).


1-palmitoyl-sn-glycerol 3-phosphate

A 1-acyl-sn-glycerol 3-phosphate having palmitoyl as the acyl group.


A triacyl-sn-glycerol in which the acyl groups at positions 1, 2 and 3 are specifed as stearoyl, arachidonoyl and oleoyl respectively.


triacylglycerol 46:5

A triglyceride in which the three acyl groups contain a total of 46 carbons and 5 double bonds.


triacylglycerol 54:3

A triglyceride in which the three acyl groups contain a total of 54 carbons and 3 double bonds.


A 2-monoglyceride where the acyl group is dodecanoyl (lauroyl).


A 1-phosphatidyl-1D-myo-inositol 3-phosphate in which both phosphatidyl acyl groups are specified as octanoyl.


triacylglycerol 52:6

A triglyceride in which the three acyl groups contain a total of 52 carbons and 6 double bonds.


phosphatidic acid 16:0

A phosphatidic acid in which the two acyl groups contain a total of 16 carbons and no double bonds.


A triacylglycerol 44:2 in which the acyl groups at positions 1, 2 and 3 are specified as decanoyl, hexadecenoyl and octadecenoyl respectively.


A triglyceride where at least the sn-2 position in the glycerol backbone has a linoleoyl chain.


A 1-O-acylglycerophosphoethanolamine having (R)-configuration.


Triglycerides which are contained in very low density lipoproteins (VLDL).


phosphatidylglycerol 38:4

A phosphatidylglycerol in which the two acyl groups contain a total of 38 carbons and 4 double bonds.


A 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as (10Z,13Z,16Z)-docosatrienoyl and (9Z,12Z)-hexadecadienoyl respectively.


A 1-acyl-2-tetradecanoyl-sn-glycero-3-phosphate in which the 1-acyl group is specified as tetradecanoyl (myristoyl).


A 3-sn-phosphatidyl-L-serine in which the phosphatidyl acyl groups at positions 1 and 2 are specified as oleoyl and stearoyl respectively.


A 3-sn-phosphatidyl-L-serine in which the 1- and 2-acyl groups are octadecanoyl and icosatrienoyl respectively.


phosphatidylglycerol 18:1/18:1

A phosphatidylglycerol 36:1 in which both acyl groups contains 18 carbons and 1 double bond.


triacylglycerol 50:7

A triglyceride in which the three acyl groups contain a total of 50 carbons and 7 double bonds.


lysophosphatidylserine 19:1

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 19 carbons and 1 double bond.


A 1-alkyl-2-acetyl-3-acyl-sn-glycerol in which the alkyl and acyl groups are specified as palmityl and capryl.


diradylglycerol

Any lipid that is glycerol bearing two substituent groups - either acyl, alkyl, or alk-1-enyl - at any two of the three possible positions.


lysophosphatidylserine 18:4

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 18 carbons and 4 double bonds.


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as stearoyl (octadecanoyl) while the phosphatidyl acyl groups are both specified as oleoyl (9Z-octadecenoyl).


A triacyl-sn-glycerol in which the which the acyl groups at positions 1, 2 and 3 are specified as hexadecanoyl, octadecanoyl and (9Z)-octadecenoyl respectively.


A 2-acyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl group is specified as arachidonoyl.


A 1-acyl-sn-glycerol that is the S-enantiomer of  2,3-dihydroxypropyl dodecanoate (glyceryl monolaurate).


triacylglycerol 56:3

A triglyceride in which the three acyl groups contain a total of 56 carbons and 3 double bonds.


A triacylglycerol 60:10 in which the acyl groups at positions 1, 2 and 3 are specified as octadecanoyl, icosatetraenoyl and docosahexaenoyl respectively.


triacylglycerol 53:2

A triglyceride in which the three acyl groups contain a total of 53 carbons and 2 double bonds.


phosphatidylserine 36:2

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 36 carbon atoms and 2 double bonds.


An N-acyl-sn-glycero-3-phosphoethanolamine in which the N-acyl group is specified as arachidonoyl (5Z,8Z,11Z,14Z-icosatetraenoyl).


monoacyl-sn-glycerol 3-phosphate

An sn-glycero-3-phosphate compound having a single unspecified acyl group at either position 1 or position 2.


A monoacylglycerol 20:5 in which the acyl group specified at position 2 is (5Z,8Z,11Z,14Z,17Z)-eicosapentaenoyl.


A triglyceride formed by acylation of the three hydroxy groups of glycerol with palmitoleic acid.


name: 15-methyl-9-hexadecenoic acid 2,3-dihydroxypropyl ester


A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as icosanoyl.


phosphatidylethanolamine 36:3

A phosphatidylethanolamine in which the acyl groups at C-1 and C-2 contain 36 carbons in total with 3 double bonds.


phosphatidylethanolamine 39:1

A phosphatidylethanolamine in which the two acyl groups contain a total of 39 carbons and 1 double bond.


phosphatidylethanolamine 33:2

A phosphatidylethanolamine in which the two acyl groups contain a total of 33 carbons and 2 double bonds.


monooctanoylglycerol

A monoglyceride in which the acyl group is octanoyl with the position of acylation unspecified.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl substituents at positions 1 and 2 are specified as icosanoyl (arachidoyl) and oleoyl respectively.


A 2-monoglyceride in which the acyl group is specified as (9E)-9-octadecenoyl.


phosphatidylserine 42:2

A 3-sn-phosphatidyl-L-serine in which the two acyl groups contain a total of 42 carbon atoms and 2 double bonds.


phosphatidylinositol mannoside

A glycosylphosphatidylinositol having mannose as the glycosyl moiety.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and octadecanoyl (stearoyl) respectively.


phosphatidic acid

A derivative of glycerol in which one hydroxy group, commonly but not necessarily primary, is esterified with phosphoric acid and the other two are esterified with fatty acids.


triacylglycerol 51:1

A triglyceride in which the three acyl groups contain a total of 51 carbons and 1 double bond.


monoacylglycerol 16:5

A monoacylglycerol in which the acyl group contains a total of 16 carbons and 5 double bonds.


triacylglycerol 50:8

A triglyceride in which the three acyl groups contain a total of 50 carbons and 8 double bonds.


A triacylglycerol 58:9 in which the acyl groups at positions 1, 2 and 3 are specified as octadecenoyl, octadecadienoyl and docosahexaenoyl respectively.


triacylglycerol 60:11

A triglyceride in which the three acyl groups contain a total of 60 carbons and 11 double bonds.


An N-acylphosphatidylethanolamine in which the N-acyl group is specified as butyryl while the phosphatidyl acyl groups at position 1 and 2 are specified as palmitoyl (hexadecanoyl) and linoleoyl (9Z,12Z-octadecadienoyl) respectively.


A 1,2-diacyl-sn-glycero-3-phospho-N-methylethanolamine in which the phosphatidyl acyl groups are both specified as oleoyl (9Z-octadecenoyl); major species at pH 7.3.


An N-acyllysophosphatidylethanolamine in which both the N- and O-acyl group are specified as oleoyl (9Z-octadecenoyl).


An N-acyllysophosphatidylethanolamine in which the N-acyl group is specified as arachidonoyl while the phosphatidyl acyl group is specified as oleoyl.


A 1-acyl-2-arachidonoyl-sn-glycero-3-phosphate in which the 1-acyl group is also arachidonoyl.


A triacylglycerol 38:0 in which the acyl groups at positions 1, 2 and 3 are specified as octanoyl, tetradecanoyl and hexadecanoyl respectively.


lysophosphatidylserine 14:0

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 14 carbons and 0 double bonds.


lysophosphatidylinositol 18:2

A lysophosphatidyl-1D-myo-inositol in which the remaining acyl group (position not specified) contains 18 carbons and 2 double bonds.


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl groups at positions 1 and 2 are specified as (11Z,14Z)-icosadienoyl and (4Z,7Z,10Z,13Z,16Z)-docosapentaenoyl respectively.


A 1-phosphatidyl-1D-myo-inositol in which the phosphatidyl acyl groups at positions 1 and 2 are specified as (8Z,11Z,14Z,17Z)-icosatetraenoyl and (11Z)-octadecenoyl respectively.


A phosphatidylglycerol 36:3 in which one acyl group has 18 carbons and 1 double bond while the other has 18 carbons and 2 double bonds (position not specified).


A triacylglycerol 62:10 in which the acyl groups at positions 1, 2 and 3 are specified as octadecanoyl, docosatetraenoyl and docosahexaenoyl respectively.


A 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate in which the phosphatidyl acyl groups at positions 1 and 2 are specified as stearoyl and arachidonoyl respectively.


A phosphatidyl-N-methylethanolamine (1,2-diacylglycero-3-phospho-N-methylethanolamine) in which the stereochemistry of the glycerol moiety is specified as sn.


A phosphatidylinositol 38:4 in which one acyl group has 18 carbons and is fully saturated while the other has 20 carbons and 4 double bonds (position not specified).


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as oleoyl and arachidonoyl respectively.


A 1-acyl-sn-glycero-3-phosphoethanolamine in which the acyl group is specified as 4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl.


glycosylmonoacylglycerol

Any glycosylmonoglyceride in which the glycosyl moiety is attached to one of the primary hydroxy groups and the acyl group position is not defined.


A 2-monoglyceride where the acyl group is tetradecanoyl (myristoyl).


1-(alk-1-enyl)-sn-glycero-3-phosphoethanolamine in which the alk-1-enyl group is specified as (E)-hexadec-1-enyl.


A 1-monoglyceride in which the acyl group is specified as (9E)-octadecenoyl.


lysophosphatidic acid 0:0/18:2(9Z,12Z)

A 2-acyl-sn-glycerol 3-phosphate having (9Z,12Z)-octadeca-9,12-dienoyl as the 2-O-acyl group.


lysophosphatidylserine 20:1

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 20 carbons and 1 double bond.


triacylglycerol 55:6

A triglyceride in which the three acyl groups contain a total of 55 carbons and 6 double bonds.


lysophosphatidylethanolamine 20:5

A lysophosphatidylethanolamine in which the acyl group (position not specified) contains 20 carbons and 5 double bonds.


A triglyceride formed by acylation of the three hydroxy groups of glycerol with linolenic acid.


A triacylglycerol 52:3 in which the acyl groups at positions 1, 2 and 3 are specified as palmitoyl, linoleoyl and oleoyl respectively.


triacylglycerol 58:4

A triglyceride in which the three acyl groups contain a total of 58 carbons and 4 double bonds.


lysophosphatidylserine 20:2

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 20 carbons and 1 double bonds.


lysophosphatidylethanolamine 18:2

A lysophosphatidylethanolamine in which the acyl group (position not specified) contains 18 carbons and 2 double bonds.


A 2-acyl-sn-glycero-3-phosphoserine in which the 2-acyl group is specified as arachidonoyl.


A 1,2-diacyl-sn-glycerol 3-phosphate in which the acyl group at position 1 is unspecified while that at position 2 is specified as oleoyl


A phosphatidylglycerol that is the 3'-O-L-lysyl of any 1,2-diacyl-sn-glycero-3-phospho-1'-sn-glycerol.


A 3-(3-sn-phosphatidyl)-sn-glycerol 1-phosphate in which both phosphatidyl acyl groups are specified as hexadecanoyl (palmitoyl).


triacylglycerol 55:10

A triglyceride in which the three acyl groups contain a total of 55 carbons and 10 double bonds.


lysophosphatidylserine 20:5

A lysophosphatidylserine in which the remaining acyl group (position not specified) contains 20 carbons and 5 double bonds.


A triacylglycerol 58:4 in which the acyl groups at positions 1, 2 and 3 are specified as octadecanoyl, icosanoyl and icosatetraenoyl respectively.


triacylglycerol 42:4

A triglyceride in which the three acyl groups contain a total of 42 carbons and 4 double bonds.


A triacylglycerol 44:2 in which the acyl groups at positions 1, 2 are specified as tetradecenoyl while that at position 3 is specified as hexadecanoyl.


glycerophosphoinositol trisphosphate

Any glycerophosphoinositol bearing three additional phospho substituents on the inositol ring.


phosphatidylinositol 3-phosphate

A phosphatidylinositol monophosphate carrying the phosphate group at the 3-position.


A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the acyl group at position 1 is unspecified while that at position 2 is specified as palmitoyl.


A 2-monoglyceride in which the acyl group is specified as (9E,12E,15E)-octadecatrienoyl.


A phosphatidylinositol 4-phosphate having 1D-myo-configuration.


triacylglycerol 52:3

A triglyceride in which the three acyl groups contain a total of 52 carbons and 3 double bonds.


CDP-acylglycerol

A CDP-glycerol compound having an acyl substituent on its primary hydroxyl group.


A 1-alkyl-2-acetyl-3-acyl-sn-glycerol in which the alkyl and acyl groups are specified as palmityl and capryloyl.


A 1-monoglyceride that has alpha-linolenoyl as the acyl group.


A phosphatidylethanolamine 35:2 in which the acyl group at C-1 contains 18 carbons and 1 double bond while that at C-2 contains 17 carbons and 1 double bond.


triacylglycerol 55:5

A triglyceride in which the three acyl groups contain a total of 55 carbons and 5 double bonds.


phosphatidylglycerol 12:0

A 1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol) in which the acyl groups at C-1 and C-2 contain 12 carbons in total with no double bonds.


triacylglycerol 55:2

A triglyceride in which the three acyl groups contain a total of 55 carbons and 2 double bonds.


LYSOPHOSPHATIDIC ACID

A 1-acyl-sn-glycerol 3-phosphate having oleoyl as the 1-O-acyl group.


trilinoleoyl 2-monolysocardiolipin

A 2-monolysocardiolipin in which all three phosphatidyl acyl groups are specified as linoleoyl.


name: Hepatitis Virus-Related Hepatocellular Carcinoma

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: A hepatocellular carcinoma that develops following hepatitis virus exposure and injury of the liver parenchyma.


Stage IIIA Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage IIIA includes: T3a, N0, M0. T3a: Multiple tumors more than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


name: Epithelioid hemangioendothelioma of liver

description: A low-grade malignant blood vessel neoplasm that arises from the liver.  It is characterized by the presence of epithelioid endothelial cells.  The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma.  Patients may be asymptomatic or present with an abdominal mass, ascites, and jaundice.


name: Stage I Intrahepatic Bile Duct Cancer AJCC v8

description: Stage I includes: IA (T1a, N0, M0); IB (T1b, N0, M0). T1a: Solitary tumor equal to or less than 5 cm without vascular invasion.  T1b: Solitary tumor larger than 5 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


Unresectable Fibrolamellar Carcinoma

description: A fibrolamellar carcinoma that is not amenable to surgical resection.


name: Hepatoblastoma with Pure Fetal Epithelial Differentiation

description: A hepatoblastoma composed of small cells resembling the fetal hepatocytes, forming thin trabeculae.


name: Recurrent Adult Hepatocellular Carcinoma

description: A hepatocellular carcinoma that occurs during adulthood and has recurred after a period of remission.


name: Locally Advanced Hepatocellular Carcinoma

description: Hepatocellular carcinoma that has spread to nearby tissues or lymph nodes.


Hepatoblastoma recurrent

description: The reemergence of hepatoblastoma after a period of remission.


name: Stage IV Childhood Hepatocellular Carcinoma AJCC v7

description: Stage IV includes: IVA: (Any T, N1, M0); IVB: (Any T, Any N, M1). N1: Regional lymph node metastasis. M0: No distant metastasis.  M1: Distant metastasis. (AJCC 7th ed.)


BCLC Stage 0 Hepatocellular Carcinoma

description: Very early hepatocellular carcinoma. Patients are optimal candidates for resection. (HPB (Oxford) 2005; 7(1):35-41)


BCLC Stage D Hepatocellular Carcinoma

description: End-stage hepatocellular carcinoma.  Patients will receive symptomatic treatment. (HPB (Oxford) 2005; 7(1):35-41)


Localized PRETEX III Hepatoblastoma

description: PRETEX III hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Adult Liver Carcinoma

description: A hepatocellular carcinoma or intrahepatic cholangiocarcinoma that occurs during adulthood.


Liver Synovial Sarcoma

description: A synovial sarcoma that affects the liver.


Stage IV Liver Cancer

description: Stage IV carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.


Metastatic Fibrolamellar Carcinoma

description: A fibrolamellar carcinoma that has spread from the liver to another anatomic site.


name: Stage III Hepatocellular Carcinoma AJCC v7

description: Stage III includes: IIIA: (T3a, N0, M0); IIIB: (T3b, N0, M0); IIIC: (T4, N0, M0). T3a: Multiple tumors more than 5 cm. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein.  T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


name: Stage IVA Hepatocellular Carcinoma AJCC v7

description: Stage IVA includes: Any T, N1, M0.  N1: Regional lymph node metastasis. M0: No distant metastasis.  (AJCC 7th ed.)


PRETEXT IV Hepatoblastoma

description: An internationally developed presurgical anatomic staging system using imaging techniques: Tumor involves all 4 quadrants; there is no quadrant free of tumor. (from PDQ 2004)


Non-Resectable Malignant Liver Neoplasm

description: A malignant liver neoplasm that is not amenable to surgical resection.


Metastatic liver carcinoma

description: A carcinoma that arises from the liver and has spread to another anatomic site.


name: Adult Pleomorphic Hepatocellular Carcinoma

description: A pleomorphic hepatocellular carcinoma that occurs during adulthood.


name: Childhood Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 2

description: A term that refers to the staging of childhood hepatoblastoma according to the tier 2 Toronto childhood cancer staging guidelines v2. It includes localized tumors, metastatic tumors, and the PRETEXT system. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Stage IV Hepatocellular Carcinoma AJCC v7


name: BCLC Stage C Adult Hepatocellular Carcinoma

description: Advanced hepatocellular carcinoma.  Patients may receive new agents in the setting of randomized controlled trials. (HPB (Oxford) 2005; 7(1):35-41)


name: Stage IV Hepatocellular Carcinoma AJCC v6

description: Stage IV includes (Any T, Any N, M1).  M1: Distant metastasis. (AJCC 6th ed.)


Extrarenal Rhabdoid Tumor of the Liver

description: A rare, aggressive primary malignant tumor of the liver that occurs in childhood.  It is characterized by the presence of a diffuse infiltrate of undifferentiated cells with rhabdoid features.


Adult Liver Embryonal Sarcoma

description: An embryonal sarcoma of the liver that occurs during adulthood.


Stage II Liver Cancer

description: Stage II carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.


Postsurgical Stage III Hepatoblastoma

description: No distant metastases, tumor unresectable or resected with gross residual tumor, or positive lymph nodes. (from PDQ 2004)


PRETEXT III Hepatoblastoma

description: An internationally developed presurgical anatomic staging system using imaging techniques: Tumor involves 3 adjoining quadrants or 2 nonadjoining quadrants; 1 quadrant or 2 nonadjoining quadrants are free of tumor. (from PDQ 2004)


Refractory Hepatoblastoma

description: Hepatoblastoma that does not respond to treatment.


Uveal Melanoma Metastatic in the Liver

description: A melanoma that originates from melanocytes of the uveal tract and has spread to the liver.


name: Stage II Hepatocellular Carcinoma AJCC v8

description: Stage II includes: T2, N0, M0. T2: Solitary tumor larger than 2 cm with vascular invasion, or multiple tumors, none larger than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Liver Small Cell Neuroendocrine Carcinoma

description: An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the liver. It is characterized by the presence of malignant small cells.


name: Stage IV Intrahepatic Bile Duct Cancer AJCC v8

description: Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)


name: Stage IIIA Hepatocellular Carcinoma AJCC v7

description: Stage IIIA includes: T3a, N0, M0.  T3a: Multiple tumors more than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


Stage III Liver Cancer

description: Stage III carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.


name: Epithelial Hepatoblastoma with Pleomorphic Pattern

description: Epithelial hepatoblastoma characterized by the presence of fetal or embryonal cells showing nuclear pleomorphism. Malignant giant cells may be present.


Stage IIIC Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage IIIC includes: T4, N0, M0.  T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


name: Stage I Hepatocellular Carcinoma AJCC v6 and v7

description: Stage I includes: T1, N0, M0.  T1: Solitary tumor without vascular invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)


Colon Carcinoma Metastatic in the Liver

description: A carcinoma that originates from the colonic wall and has spread to the liver.


name: Stage III Hepatocellular Carcinoma AJCC v8

description: Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0). T3: Multiple tumors, at least one of which is larger than 5 cm. T4: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein, or tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


Non-Teratoid Hepatoblastoma

description: A mixed epithelial and mesenchymal hepatoblastoma characterized by the absence of heterologous elements, muscle, cartilage or osteoid.


name: Stage IIIA Intrahepatic Bile Duct Cancer AJCC v8

description: Stage IIIA includes: T3, N0, M0. T3: Tumor perforating the visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Liver Mixed Adenoneuroendocrine Carcinoma

description: A carcinoma that arises from the liver and is characterized by the presence of a malignant glandular epithelial component and a malignant neuroendocrine component.  At least 30 percent of either component should be present for the diagnosis to be made.


name: Moderately Differentiated Hepatocellular Carcinoma

description: A hepatocellular carcinoma characterized by the presence of malignant cells with abundant eosinophilic cytoplasm forming trabecular and pseudoglandular patterns.  It is usually associated with tumors that are larger than 3 cm in diameter.


name: Hepatocellular carcinoma, spindle cell variant

description: A morphologic variant of hepatocellular carcinoma characterized by the presence of malignant spindle cells or atypical giant cells.


carcinosarcoma of liver

description: An aggressive carcinoma with a sarcomatous component that arises from the liver.  The sarcomatous component is clonally related to the more differentiated, carcinomatous component.  The prognosis is usually poor.


Hepatic cancer stage IVA

description: Stage IVA carcinoma of the liver according to the American Joint Committee on Cancer, 7th and 8th editions.


name: Stage II Intrahepatic Bile Duct Cancer AJCC v8

description: Stage II includes: T2, N0, M0. T2: Solitary tumor with intrahepatic vascular invasion, or multiple tumors, with or without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Hepatocellular Malignant Neoplasm, Not Otherwise Specified

description: A rare childhood malignant liver neoplasm with overlapping features of hepatoblastoma and hepatocellular carcinoma.


name: Stage I Childhood Hepatocellular Carcinoma AJCC v6 and v7


Locally Advanced Liver Carcinoma

description: Liver carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes.


Teratoid Hepatoblastoma

description: A mixed epithelial and mesenchymal hepatoblastoma characterized by the presence of heterologous elements. The latter include neuroectoderm, endoderm, or melanin-holding cells. Muscle, cartilage and osteoid may or may not be present.


BCLC Stage B Hepatocellular Carcinoma

description: Intermediate hepatocellular carcinoma.  Patients may benefit from chemoembolization. (HPB (Oxford) 2005; 7(1):35-41)


Kaposi's sarcoma of liver

description: A Kaposi sarcoma that arises from the liver.


name: Stage IA Intrahepatic Bile Duct Cancer AJCC v8

description: Stage IA includes: T1a, N0, M0. T1a: Solitary tumor equal to or less than 5 cm without vascular invasion.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


description: Hepatocellular carcinoma characterized by the presence of diffuse neutrophil infiltrates within the tumor.


Stage IIIB Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage IIIB includes: T3b, N0, M0. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


name: Childhood Hepatoblastoma by Toronto Guidelines v2 Stage

description: A term that refers to the staging of childhood hepatoblastoma according to the Toronto childhood cancer staging guidelines v2.


Metastatic malignant neoplasm to liver

description: A malignant neoplasm that has spread to the liver from another (primary) anatomic site. Representative examples include carcinomas, lymphomas, melanomas, or sarcomas.


name: Stage 0 Intrahepatic Bile Duct Cancer AJCC v8

description: Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ (intraductal tumor). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


Metastatic hepatocellular carcinoma

description: A hepatocellular carcinoma that has spread to another anatomic site.


name: Unresectable Liver and Intrahepatic Bile Duct Carcinoma

description: Liver carcinoma that is not amenable to surgical resection.


Childhood Liver Embryonal Sarcoma

description: An embryonal sarcoma of the liver that occurs during childhood.


name: Recurrent Childhood Hepatocellular Carcinoma

description: A hepatocellular carcinoma that occurs during childhood and has recurred after a period of remission.


Malignant Liver Non-Epithelial Neoplasm

description: A primary or metastatic malignant non-epithelial neoplasm that affects the liver.


name: BCLC Stage B Adult Hepatocellular Carcinoma


name: Hepatocellular Carcinoma by AJCC v8 Stage

description: A term that refers to the staging of hepatocellular carcinoma according to the American Joint Committee on Cancer, 8th edition. This staging system applies to hepatocellular carcinomas and fibrolamellar carcinomas (fibrolamellar variant of hepatocellular carcinoma). Intrahepatic cholangiocarcinomas, combined hepatocellular-cholangiocarcinomas, and sarcomas of the liver are not staged using this staging system. (from AJCC 8th Ed.)


description: A hepatocellular carcinoma that arises in a patient with a history of organ transplantation.


name: Hepatitis B Virus-Related Hepatocellular Carcinoma

description: A hepatocellular carcinoma that develops following hepatitis B virus exposure and injury of the liver parenchyma.


name: Hepatitis C Virus-Related Hepatocellular Carcinoma

description: A hepatocellular carcinoma that develops following hepatitis C virus exposure and injury of the liver parenchyma.


name: BCLC Stage 0 Adult Hepatocellular Carcinoma

description: Very early hepatocellular carcinoma. Patients are optimal candidates for resection. (HPB (Oxford) 2005; 7(1):35-41)


name: Localized Non-Resectable Adult Liver Carcinoma

description: A localized hepatocellular carcinoma or intrahepatic cholangiocarcinoma that occurs during adulthood and it is not amenable to surgical resection.


Recurrent Childhood Liver Cancer

description: A malignant neoplasm of the liver that occurs during childhood and has recurred after a period of remission.


Liver Yolk Sac Tumor

description: A yolk sac tumor that arises from the liver.


Stage I Liver Carcinoma

description: Stage I carcinoma of the liver according to the American Joint Committee on Cancer, 6th, 7th, and 8th editions.


name: Colorectal Adenocarcinoma Metastatic in the Liver

description: An adenocarcinoma that originates from the colorectal area and has spread to the liver.


name: Stage IV Hepatocellular Carcinoma AJCC v8

description: Stage IV includes: IVA: (Any T, N1, M0); IVB: (Any T, Any N, M1). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)


Postsurgical Stage IV Hepatoblastoma

description: Distant metastases, regardless of the extent of liver involvement. (from PDQ 2004)


name: Localized Childhood Hepatoblastoma by Toronto Guidelines v2, Tier1

description: Tumor confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Small Cell Undifferentiated Hepatoblastoma

description: A hepatoblastoma composed exclusively of noncohesive sheets of small undifferentiated cells. Cases showing loss of INI1 nuclear staining should be classified as rhabdoid tumors.


name: Metastatic Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 2

description: Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Postsurgical Stage I Hepatoblastoma

description: No metastases, tumor completely resected. (from PDQ 2004)


name: Well Differentiated Hepatocellular Carcinoma

description: A hepatocellular carcinoma characterized by the presence of malignant cells with mild atypia and an increased nuclear/cytoplasmic ratio forming thin trabecular patterns.  It is usually associated with small tumors and an early stage.


name: Stage IB Intrahepatic Bile Duct Cancer AJCC v8

description: Stage IB includes: T1b, N0, M0. T1b: Solitary tumor larger than 5 cm without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


Childhood Fibrolamellar Carcinoma

description: A fibrolamellar variant of hepatocellular carcinoma that occurs during childhood.


Recurrent Liver Carcinoma

description: The reemergence of liver carcinoma after a period of remission.


name: Stage IVA Hepatocellular Carcinoma AJCC v8

description: Stage IVA includes: Any T, N1, M0. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: BCLC Stage A Adult Hepatocellular Carcinoma

description: Early hepatocellular carcinoma.  Patients are candidates for radical therapies (resection, liver transplantation, or percutaneous treatments). (HPB (Oxford) 2005; 7(1):35-41)


Metastatic Hepatoblastoma

description: Hepatoblastoma that has spread from its original site of growth to another anatomic site.


name: Childhood Hepatoblastoma by Toronto Guidelines v2 Stage, Tier 1

description: A term that refers to the staging of childhood hepatoblastoma according to the tier 1 Toronto childhood cancer staging guidelines v2.


Stage II Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage II includes: T2, N0, M0. T2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis.  For intrahepatic cholangiocarcinoma: Stage II includes: T2, N0, M0. T2: Solitary tumor with vascular invasion or multiple tumors, with or without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)


name: Stage III Childhood Hepatocellular Carcinoma AJCC v7

description: Stage III includes: IIIA: (T3a, N0, M0); IIIB: (T3b, N0, M0); IIIC: (T4, N0, M0). T3a: Multiple tumors more than 5 cm. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein.  T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


Hepatoblastoma by PRETEXT Stage

description: A term that refers to the staging of hepatoblastoma, following the rules of the PRETEXT (pre-treatment extent of tumor) system.


Localized PRETEX I Hepatoblastoma

description: PRETEX I hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Hepatoblastoma resectable

description: Hepatoblastoma amenable to surgical removal.


name: Stage IVB Hepatocellular Carcinoma AJCC v8

description: Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)


name: Hepatocellular Carcinoma by AJCC v7 Stage

description: A term that refers to the staging of hepatocellular carcinoma according to the American Joint Committee on Cancer, 7th edition.


name: Stage IIIB Hepatocellular Carcinoma AJCC v8

description: Stage IIIB includes: T4, N0, M0. T4: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein, or tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Localized Unresectable Adult Hepatocellular Carcinoma

description: A localized hepatocellular carcinoma that occurs during adulthood and it is not amenable to surgical resection.


Adult Fibrolamellar Carcinoma

description: Fibrolamellar variant of hepatocellular carcinoma that occurs during adulthood.


name: Poorly Differentiated Hepatocellular Carcinoma

description: A hepatocellular carcinoma characterized by the presence of malignant pleomorphic cells forming solid patterns.


Recurrent Fibrolamellar Carcinoma

description: The reemergence of fibrolamellar carcinoma after a period of remission.


undifferentiated carcinoma of liver

description: A rare carcinoma that arises from the liver.  The diagnosis is made by immunohistochemical studies.  Morphologic studies alone cannot establish the diagnosis of carcinoma or further subclassify the malignant tumor.


description: A hepatocellular carcinoma that develops following alcohol-induced injury of the liver parenchyma.


name: Stage IVB Hepatocellular Carcinoma AJCC v7

description: Stage IVB includes: Any T, Any N, M1.  M1: Distant metastasis. (AJCC 7th ed.)


BCLC Stage C Hepatocellular Carcinoma

description: Advanced hepatocellular carcinoma.  Patients may receive new agents in the setting of randomized controlled trials. (HPB (Oxford) 2005; 7(1):35-41)


Stage I Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage I includes: T1, N0, M0. T1: Solitary tumor without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis.  For intrahepatic cholangiocarcinoma: Stage I includes: T1, N0, M0. T1: Solitary tumor without vascular invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)


Small Hepatocellular Carcinoma

description: Hepatocellular carcinoma measuring equal to or less than 2 cm in diameter. It includes early hepatocellular carcinoma and small progressed hepatocellular carcinoma.


Hepatoblastoma by Postsurgical Stage

description: A term that refers to the staging of hepatoblastoma according to post-operative findings.


Pleomorphic Hepatocellular Carcinoma

description: A morphologic variant of hepatocellular carcinoma, characterized by the presence of malignant cells which show marked variation in their size and shape. Bizarre mononuclear or multinucleated giant cells are often present.


name: Stage IIIB Hepatocellular Carcinoma AJCC v7

description: Stage IIIB includes: T3b, N0, M0. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein.  N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


Stage III Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage III includes: IIIA: (T3a, N0, M0); IIIB: (T3b, N0, M0); IIIC: (T4, N0, M0). T3a: Multiple tumors more than 5 cm. T3b: Single tumor or multiple tumors of any size involving a major branch of the portal vein or hepatic vein. T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis.  For intrahepatic cholangiocarcinoma: Stage III includes: T3, N0, M0. T3: Tumor perforating the visceral peritoneum or involving the local extra hepatic structures by direct invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 7th Ed.)


name: large cell neuroendocrine carcinoma of liver

description: An aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the liver. It is characterized by the presence of malignant large cells.


PRETEXT I Hepatoblastoma

description: An internationally developed presurgical anatomic staging system using imaging techniques: Tumor involves only 1 quadrant; 3 adjoining liver quadrants are free of tumor. (from PDQ 2004)


name: Hepatocellular Carcinoma by AJCC v6 Stage

description: A term that refers to the staging of hepatocellular carcinoma according to the American Joint Committee on Cancer, 6th edition.


Childhood Liver Angiosarcoma

description: An angiosarcoma that arises from the liver during childhood. Most cases arise within preexisting liver infantile hemangiomas.


Epithelial Hepatoblastoma

description: A subtype of hepatoblastoma characterized by the presence of an epithelial component and absence of mesenchymal elements. It includes hepatoblastoma with pure fetal epithelial differentiation, hepatoblastoma with combined fetal and embryonal epithelial differentiation, macrotrabecular hepatoblastoma, and small cell undifferentiated hepatoblastoma (small cell undifferentiated hepatoblastoma with loss of INI1 nuclear staining should be classified as rhabdoid tumor).


Hepatocellular Carcinoma by BCLC Stage

description: A staging classification system for hepatocellular carcinoma that uses variables related to tumor stage, liver functional status, physical status, and cancer-related symptoms, and links the stages with a treatment algorithm. (HPB (Oxford) 2005; 7(1):35-41)


name: Metastatic Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 1

description: Distant metastases present. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Hepatoblastoma non-resectable

description: Hepatoblastoma not amenable to surgical removal.


name: Intrahepatic Bile Duct Cancer by AJCC v8 Stage

description: A term that refers to the staging of intrahepatic bile duct cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to intrahepatic cholangiocarcinomas, combined hepatocellular-cholangiocarcinomas (mixed hepatocholangiocarcinomas), and primary neuroendocrine tumors of the liver. Primary sarcomas of the liver, pure hepatocellular carcinomas, hilar cholangiocarcinomas, and gallbladder carcinomas are not staged using this staging system. (from AJCC 8th Ed.)


name: Stage III Intrahepatic Bile Duct Cancer AJCC v8

description: Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0); (Any T, N1, M0). T3: Tumor perforating the visceral peritoneum. T4: Tumor involving local extrahepatic structures by direct invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


Chromophobe Hepatocellular Carcinoma

description: Hepatocellular carcinoma characterized by the presence of malignant cells with smooth chromophobic cytoplasm, abrupt focal nuclear anaplasia, and scattered microscopic pseudocysts.


Recurrent Hepatocellular Carcinoma

description: The reemergence of hepatocellular carcinoma after a period of remission


BCLC Stage A Hepatocellular Carcinoma

description: Early hepatocellular carcinoma.  Patients are candidates for radical therapies (resection, liver transplantation, or percutaneous treatments). (HPB (Oxford) 2005; 7(1):35-41)


Refractory Liver Carcinoma

description: Liver carcinoma that is resistant to treatment.


Stage IVB Liver Cancer

description: Stage IVB carcinoma of the liver according to the American Joint Committee on Cancer, 7th and 8th editions.


Metastatic PRETEX III Hepatoblastoma

description: PRETEX III hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Refractory Hepatocellular Carcinoma

description: Hepatocellular carcinoma that is resistant to treatment.


Localized PRETEX II Hepatoblastoma

description: PRETEX II hepatoblastoma confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Metastatic carcinoma to liver

description: A carcinoma that has spread to the liver from another primary anatomic site.  Representative examples include metastatic carcinomas from the colon, breast, and lung.


name: Localized Childhood Hepatoblastoma by Toronto Guidelines v2, Tier 2

description: Tumor confined to the liver including regional lymph nodes. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Early Hepatocellular Carcinoma

description: A low grade, well differentiated small hepatocellular carcinoma. It lacks obvious stromal invasion and significant atypia.


Metastatic PRETEX IV Hepatoblastoma

description: PRETEX IV hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Liver Plasmacytoma

description: A plasmacytoma that arises in the liver.


name: Stage II Hepatocellular Carcinoma AJCC v6 and v7

description: Stage II includes: T2, N0, M0.  T2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)


description: A rare type of hepatocellular carcinoma characterized by the presence of pleomorphic malignant cells that are intermixed with lymphocytes.


name: Stage III Hepatocellular Carcinoma AJCC v6

description: Stage III includes: IIIA: (T3, N0, M0); IIIB: (T4, N0, M0); IIIC: (Any T, Any N, M0).  IIIA: T3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s).  T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum.  N0: No regional lymph node metastasis.  N1: Regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th ed.)


PRETEXT II Hepatoblastoma

description: An internationally developed presurgical anatomic staging system using imaging techniques: Tumor involves 2 adjoining quadrants; 2 adjoining quadrants are free of tumor. (from PDQ 2004)


Stage IV Adult Liver Cancer AJCC v7

description: For hepatocellular carcinoma: Stage IV includes: IVA: (Any T, N1, M0); IVB: (Any T, Any N, M1). N1: Regional lymph node metastasis. M0: No distant metastasis. M1: Distant metastasis.  For intrahepatic cholangiocarcinoma: Stage IVA includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor with periductal invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis.  Stage IVB includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 7th Ed.)


Unresectable Hepatocellular Carcinoma

description: A hepatocellular carcinoma that is not amenable to surgical resection.


name: Hepatoblastoma with Combined Fetal and Embryonal Epithelial Differentiation

description: A hepatoblastoma composed of cells resembling fetal epithelial cells and small round cells resembling blastema cells.


name: Rectal Carcinoma Metastatic in the Liver

description: A carcinoma that originates from the rectum and has spread to the liver.


name: Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma

description: A combined hepatocellular carcinoma and cholangiocarcinoma that occurs during adulthood.


name: Stage IIIA Hepatocellular Carcinoma AJCC v8

description: Stage IIIA includes: T3, N0, M0. T3: Multiple tumors, at least one of which is larger than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


name: Stage IIIC Hepatocellular Carcinoma AJCC v7

description: Stage IIIC includes: T4, N0, M0.  T4: Tumors(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 7th ed.)


Childhood Malignant Liver Neoplasm

description: A malignant neoplasm that affects the liver and occurs during childhood.


name: BCLC Stage D Adult Hepatocellular Carcinoma

description: End-stage hepatocellular carcinoma.  Patients will receive symptomatic treatment. (HPB (Oxford) 2005; 7(1):35-41)


name: Macrotrabecular Massive Hepatocellular Carcinoma

description: Hepatocellular carcinoma characterized by more than 50% growth of macrotrabecular pattern (equal to or more than 6 to 10 cells thick). It presents with higher grade and stage compared to conventional hepatocellular carcinoma. It has poor prognosis with early recurrence and poor overall survival.


name: Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7


Metastatic PRETEX II Hepatoblastoma

description: PRETEX II hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Early Stage Hepatocellular Carcinoma

description: A stage term referring to hepatocellular carcinoma that presents as a single tumor with the largest diameter measuring 2 cm or less. The liver function is well-preserved and there is no vascular invasion or metastasis. (Barcelona Liver Cancer Classification).


name: Stage IIIB Intrahepatic Bile Duct Cancer AJCC v8

description: Stage IIIB includes: (T4, N0, M0); (Any T, N1, M0). T4: Tumor involving local extrahepatic structures by direct invasion. N0: No regional lymph node metastasis. N1: Regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)


description: Hepatocellular carcinoma characterized by the presence of steatohepatitis features, including macrovesicular steatosis, fibrosis, ballooning of malignant hepatocytes, Mallory bodies, and inflammation.


name: Colorectal Carcinoma Metastatic in the Liver

description: A carcinoma that originates from the colorectal area and has spread to the liver.


Metastatic PRETEX I Hepatoblastoma

description: PRETEX I hepatoblastoma with distant metastases. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Small Progressed Hepatocellular Carcinoma

description: A well to moderately differentiated small hepatocellular carcinoma. It is characterized by the presence of obvious stromal invasion and increase atypia compared with early hepatocellular carcinoma.


Recurrent Adult Liver Carcinoma

description: A hepatocellular carcinoma or intrahepatic cholangiocarcinoma that occurs during adulthood and has recurred after a period of remission.


yanuthone F

A class I yanuthone that is 7-deacetoxyyanuthone A in which one of the hydrogens of the trans-terminal methyl groups of the sesquiterpenoid side-chain has been replaced by a hydroxy group.


name: Grade II Prostatic Intraepithelial Neoplasia

description: High grade prostatic intraepithelial neoplasia characterized by the presence of moderate architectural and cytologic abnormalities.


name: Testicular Tumor of the Thecoma/Fibroma Group

description: A group of rare, slow-growing stromal tumors that arise from the testis.  This category includes thecoma and fibroma.


Testicular Signet Ring Stromal Tumor

description: An extremely rare tumor that arises from the testis. It is characterized by the proliferation of epithelioid cells with signet ring appearance separated by fibrous tissue into trabeculae and nests. The histologic features are bland and there is no mucin production. Mutations of CTNNB1 gene have been identified in the reported cases. It is considered a special type of sex cord-stromal tumor. All reported cases had a benign clinical course without metastases.


name: recurrent childhood acute myeloid leukemia

description: The reemergence of acute myeloid leukemia in childhood after a period of remission.


A secondary fatty alcohol that is hexacosane substituted by a hydroxy group at position 13.


name: Stage IV Gestational Trophoblastic Neoplasm AJCC v8

description: Stage IV includes: Any T, M1b. M1b: Gestational trophoblastic neoplasm with all other distant metastases. (AJCC 8th Ed.)


name: Childhood Unfavorable Prognosis Hodgkin Lymphoma

description: A Hodgkin lymphoma with unfavorable prognosis that occurs during childhood.


Acquired Factor III Deficiency

description: An acquired coagulation disorder characterized by the partial or complete absence of tissue factor (factor III) activity in the blood.


Factor III deficiency

description: A coagulation disorder characterized by the partial or complete absence of tissue factor (factor III) activity in the blood.


Factor III Inactivation

description: Presence of inactivating antibodies to tissue factor (factor III) in the blood.


Hereditary Factor III Deficiency

description: An autosomal recessive, inherited coagulation disorder characterized by the partial or complete absence of tissue factor (factor III) activity in the blood.


Acardius

description: A severe form of twin-twin transfusion syndrome that occurs in monochorionic pregnancies. The normal twin (pump twin) supplies the blood flow to its sibling that lacks heart or brain or both (acardiac/acephalic twin). Untreated, it may lead to the demise of the pump twin in some cases.


Parkinson Disease 9

description: An autosomal recessive subtype of Parkinson disease, caused by mutation(s) in the ATP13A2 gene, encoding polyamine-transporting ATPase 13A2.


name: Parkinson Disease 23, Autosomal Recessive, Early Onset

description: An autosomal recessive subtype of Parkinson disease, caused by mutation(s) in the VPS13C gene, encoding intermembrane lipid transfer protein VPS13C.


Parkinson Disease 20, Early-Onset

description: An autosomal recessive subtype of Parkinson disease, caused by mutation(s) in the SYNJ1 gene, encoding synaptojanin-1.


isotridecanoyl-CoA

A methyl-branched fatty acyl-CoA obtained from the formal condensation of the thiol group of coenzyme A with the carboxy group of isotridecanoic acid